Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
General Dynamics Corporation., In the Matter of
The consent order settled charges that General Dynamics’ proposed $275 million acquisition of SNC Technologies, Inc. and SNC Technologies, Corp. would likely undermine competition by bringing together two of only three competitors providing the U.S. military with melt-pour load, assemble, and pack (LAP) services used during the manufacture of ammunition for mortars and artillery. Absent relief, the proposed acquisition would likely force the U.S. military to pay higher prices for these munitions. General Dynamics is required to sell its interest in American Ordnance to an FTC-approved buyer within four months of acquiring SNC.
Duncan, Dan L., EPCO, Inc., Texas Eastern Products Pipeline Company, LLC, and TEPPCO Partners, LP, In the Matter of
Information Search, Inc., and David J. Kacala (District of Maryland, Northern Division)
Consumerinfo.com., Inc., d/b/a Experian Consumer Direct, Qspace, Inc., and Iplace Inc.
Goen Technologies Corporation, Nutramerica Corporation, et al., In the Matter of
Dissenting Statement of Commissioner Jon Leibowitz In the Matter of DirectRevenue LLC
Remedy Statement of Commissioner Pamela Jones Harbour, Concurring in Part and Dissenting in Part In the Matter of Rambus Inc
Opinion of the Commission On Remedy In the Matter of Rambus Inc. by Chairman Deborah Platt Majoras
Broadcast Team, The, Inc., Plaintiff, v. FTC, Defendant
Broadcast Team, The, Inc., et al.
TJ Web Productions, LLC, et al., US vs
TC Group, LLC., Riverstone Holdings LLC, Carlyle/Riverstone Global Energy and Power Fund II, LP, and Carlyle/Riverstone Global Energy and Power Fund III, LP, In the Matter of
Proposed Acquisition of McData Corporation by Brocade Communications Systems Inc.
Johnson & Johnson and Pfizer Inc., In the Matter of
The consent order settles charges that Johnson & Johnson’s (J&J) proposed $16.6 billion acquisition of Pfizer Inc.’s (Pfizer) Consumer Healthcare business would likely reduce competition in the U.S. markets for over-the-counter (OTC) H-2 blockers used to prevent and relieve heartburn, OTC hydrocortisone anti-itch products, OTC night-time sleep aids, and OTC diaper rash treatments. In settling the Commission’s charges, the companies have agreed to sell Pfizer’s Zantac H-2 blocker business to Boehringer Ingelheim Pharmaceuticals Inc. (Boehringer), and Pfizer’s Cortizone hydrocortisone anti-itch business, Pfizer’s Unisom night-time sleep aid business, and J&J’s Balmex diaper rash treatment business to Chattem, Inc.